13F filer · CIK 93751 ↗
State Street
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$1.28T
+17% on the quarter before
Positions
3,743
77 new · 95 sold out
Top 10
16.8%
of the value
Est. gain
+$142.10B
on stocks held all quarter
Est. return
+13.1%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from State Street's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Walt Disney Company (The)~$1.62BAdded · 0.6% → 0.6%+14,615,600 shares
- Amazon~$1.36BAdded · 2.2% → 2.3%+762,363 shares
- Southwest Airls Co~$1.25BAdded · 0.1% → 0.2%+24,063,315 shares
- Microsoft~$1.12BAdded · 2.8% → 2.9%+9,503,045 shares
- Meta~$1.07BAdded · 1.0% → 1.2%+6,389,153 shares
- Apple~$993.5MAdded · 2.7% → 2.8%+5,230,504 shares
- Alphabet~$887.1MAdded · 1.0% → 1.1%+756,039 shares
- Alphabet~$881.8MAdded · 1.0% → 1.1%+749,267 shares
- Alibaba~$789.8MAdded · 0.3% → 0.4%+4,328,968 shares
- Dominion Energy~$584.2MAdded · 0.2% → 0.2%+7,621,093 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twenty First Centy Fox Inc~$1.83BSold out · 0.2% → 0.0%−38,120,388 shares
- Twenty First Centy Fox Inc~$808.0MSold out · 0.1% → 0.0%−16,909,789 shares
- Pg&E Corp~$354.1MCut · 0.1% → 0.0%−19,890,505 shares
- Apartment Invt & Mgmt Co~$353.9MSold out · 0.0% → 0.0%−8,064,072 shares
- Vectren Corp~$341.8MSold out · 0.0% → 0.0%−4,749,215 shares
- Michael Kors Hldgs Ltd~$244.3MSold out · 0.0% → 0.0%−6,443,090 shares
- Enbridge Inc~$239.0MCut · 0.0% → 0.0%−6,589,970 shares
- Morgan Stanley~$221.8MCut · 0.5% → 0.4%−5,255,781 shares
- Steris Plc~$218.2MSold out · 0.0% → 0.0%−2,041,689 shares
- Eli Lilly~$179.0MCut · 0.4% → 0.4%−1,379,523 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +3.1% · price +16.1% | 2.9% | $36.93B | +$4.97B | ||||||||
| AppleCOM · shares +2.8% · price +20.4% | 2.8% | $36.21B | +$5.97B | ||||||||
| AmazonCOM · shares +4.8% · price +18.6% | 2.3% | $29.45B | +$4.40B | ||||||||
| Johnson & JohnsonCOM · shares +2.3% · price +8.3% | 1.7% | $21.69B | +$1.63B | ||||||||
| Exxon Mobil CorpCOM · shares +0.5% · price +18.5% | 1.3% | $16.50B | +$2.56B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −0.9% · price −1.6% | 1.2% | $15.70B | −$257.2M | ||||||||
| MetaCL A · shares +7.4% · price +27.2% | 1.2% | $15.44B | +$3.07B | ||||||||
| Jpmorgan Chase & CoCOM · shares −0.2% · price +3.7% | 1.2% | $15.21B | +$542.2M | ||||||||
| Chevron Corp NewCOM · shares +0.5% · price +13.2% | 1.1% | $14.21B | +$1.65B | ||||||||
| AlphabetCAP STK CL C · shares +6.9% · price +13.3% | 1.1% | $13.66B | +$1.50B | ||||||||
| AlphabetCAP STK CL A · shares +7.0% · price +12.6% | 1.1% | $13.52B | +$1.42B | ||||||||
| Lockheed Martin CorpCOM · shares +0.8% · price +14.6% | 1.1% | $13.51B | +$1.71B | ||||||||
| Pfizer IncCOM · shares +1.1% · price −2.7% | 0.99% | $12.63B | −$347.2M | ||||||||
| Visa Inc.COM CL A · shares +2.7% · price +18.4% | 0.95% | $12.22B | +$1.85B | ||||||||
| Procter And Gamble CoCOM · shares +2.6% · price +13.2% | 0.93% | $11.97B | +$1.36B | ||||||||
| United Technologies CorpCOM · shares +0.4% · price +21.0% | 0.91% | $11.61B | +$2.01B | ||||||||
| Unitedhealth Group IncCOM · shares +3.7% · price −0.7% | 0.90% | $11.51B | −$83.5M | ||||||||
| Bank Amer CorpCOM · shares +0.04% · price +12.0% | 0.84% | $10.80B | +$1.15B | ||||||||
| IntelCOM · shares +2.2% · price +14.4% | 0.82% | $10.55B | +$1.30B | ||||||||
| CiscoCOM · shares +0.9% · price +24.6% | 0.81% | $10.40B | +$2.03B | ||||||||
| Home Depot IncCOM · shares +1.8% · price +11.7% | 0.79% | $10.15B | +$1.04B | ||||||||
| Boeing CoCOM · shares +1.0% · price +18.3% | 0.78% | $10.02B | +$1.53B | ||||||||
| Merck & Co IncCOM · shares +5.0% · price +8.8% | 0.77% | $9.81B | +$754.5M | ||||||||
| Verizon Communications IncCOM · shares +6.0% · price +5.2% | 0.74% | $9.55B | +$443.2M | ||||||||
| AT&TCOM · shares +6.5% · price +9.9% | 0.73% | $9.31B | +$786.2M | ||||||||
| Total · 3,743 positions | 100% | $1.28T | +$142.10B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 3,666 stocks held throughout, up $142.10B (+13.1%).
- Apple+$5.97B+20%
- Microsoft+$4.97B+16%
- Amazon+$4.40B+19%
- Meta+$3.07B+27%
- Exxon Mobil Corp+$2.56B+18%
- Cigna Corp New−$471.1M−15%
- Centene Corp Del−$518.6M−54%
- Biogen Inc−$565.0M−21%
- Cvs Health Corp−$674.5M−18%
- Abbvie Inc−$745.5M−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Sep 22, 2026 (amended) | $3.38T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.90T−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $2.98T+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.88T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.67T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $2.43T−4% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $2.53T+3% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.46T+7% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.29T+2% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.24T+9% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $2.06T+14% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $1.80T−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.90T+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $1.77T+4% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $1.70T+8% | SEC ↗ |
| Q3 2022 | Nov 15, 2022 | $1.58T−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.67T−17% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.02T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.11T+11% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $1.89T−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $1.90T+9% | SEC ↗ |
| Q1 2021 | Jul 9, 2021 (amended) | $1.74T+7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $1.63T+12% | SEC ↗ |
| Q3 2020 | Nov 10, 2020 | $1.46T+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $1.38T+20% | SEC ↗ |
| Q1 2020 | Jun 19, 2020 (amended) | $1.14T−22% | SEC ↗ |
| Q4 2019 | Feb 6, 2020 | $1.46T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 (amended) | $1.34T+0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.34T+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $1.28T+17% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $1.10T−16% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $1.30T+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $1.20T+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.18T−5% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.24T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.16T+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.13T+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.12T+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $1.06T+7% | SEC ↗ |
| Q3 2016 | Jan 13, 2017 (amended) | $992.21B+7% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $930.88B+1% | SEC ↗ |
| Q1 2016 | May 20, 2016 (amended) | $924.92B | SEC ↗ |